Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity
出版年份 2019 全文链接
标题
Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity
作者
关键词
-
出版物
Cancers
Volume 12, Issue 1, Pages 24
出版商
MDPI AG
发表日期
2019-12-23
DOI
10.3390/cancers12010024
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The ERBB-STAT3 Axis Drives Tasmanian Devil Facial Tumor Disease
- (2019) Lindsay Kosack et al. CANCER CELL
- MicroRNA-503-5p Inhibits the CD97-Mediated JAK2/STAT3 Pathway in Metastatic or Paclitaxel-Resistant Ovarian Cancer Cells
- (2019) Ga Bin Park et al. NEOPLASIA
- Inhibition of Heat Shock Protein 90 suppresses TWIST1 Transcription
- (2019) Kay Yi Chong et al. MOLECULAR PHARMACOLOGY
- Role of cancer-associated fibroblasts in tumor structure, composition and the microenvironment in ovarian cancer (Review)
- (2019) Wei Sun et al. Oncology Letters
- The Role of Epithelial-to-Mesenchymal Plasticity in Ovarian Cancer Progression and Therapy Resistance
- (2019) Nele Loret et al. Cancers
- Direct Targeting Options for STAT3 and STAT5 in Cancer
- (2019) Anna Orlova et al. Cancers
- Co-culture of ovarian cancer stem-like cells with macrophages induced SKOV3 cells stemness via IL-8/STAT3 signaling
- (2018) Yingxia Ning et al. BIOMEDICINE & PHARMACOTHERAPY
- Mutations in the signal transducer and activator of transcription family of genes in cancer
- (2018) Nahid Shahmarvand et al. CANCER SCIENCE
- AKT2 contributes to increase ovarian cancer cell migration and invasion through the AKT2-PKM2-STAT3/NF-κB axis
- (2018) Bin Zheng et al. CELLULAR SIGNALLING
- Pterostilbene Suppresses Ovarian Cancer Growth via Induction of Apoptosis and Blockade of Cell Cycle Progression Involving Inhibition of the STAT3 Pathway
- (2018) Wei Wen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity
- (2018) Ali R. Özeş et al. ONCOGENE
- Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteins
- (2018) Kalpana Deepa Priya Dorayappan et al. ONCOGENE
- Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance
- (2018) Wei Zhou et al. ONCOGENE
- CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway
- (2018) Linlin Wang et al. ONCOLOGY REPORTS
- Advances of exosome in the development of ovarian cancer and its diagnostic and therapeutic prospect
- (2018) Jiayu Shen et al. OncoTargets and Therapy
- Influence of c-Src on hypoxic resistance to paclitaxel in human ovarian cancer cells and reversal of FV-429
- (2018) Qinglong Guo et al. Cell Death & Disease
- JAK2/STAT3 pathway as a therapeutic target in ovarian cancers
- (2018) Tomoyuki Yoshikawa et al. Oncology Letters
- Ruxolitinib synergistically enhances the anti-tumor activity of paclitaxel in human ovarian cancer
- (2018) Ernest S. Han et al. Oncotarget
- Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer
- (2018) Emily Chan et al. Oncotarget
- 3,3′-Diindolylmethane suppresses ovarian cancer cell viability and metastasis and enhances chemotherapy sensitivity via STAT3 and Akt signaling in vitro and in vivo
- (2018) Minghua Zou et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- STAT3 regulatedmiR-216apromotes ovarian cancer proliferation and cisplatin resistance
- (2018) Pengfei Jin et al. BIOSCIENCE REPORTS
- The BET bromodomain inhibitor i-BET151 impairs ovarian cancer metastasis and improves antitumor immunity
- (2018) Ai Liu et al. CELL AND TISSUE RESEARCH
- A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plusnab‐Paclitaxel and Gemcitabine in Advanced Solid Tumors
- (2018) Gregory L. Beatty et al. ONCOLOGIST
- Cryptotanshinone suppresses cell proliferation and glucose metabolism via STAT3/SIRT3 signaling pathway in ovarian cancer cells
- (2018) Yufei Yang et al. Cancer Medicine
- The Long Noncoding RNA MEG3 and its Target miR-147 Regulate JAK/STAT Pathway in Advanced Chronic Myeloid Leukemia
- (2018) Zi-ye Li et al. EBioMedicine
- Celastrol strongly inhibits proliferation, migration and cancer stem cell properties through suppression of Pin1 in ovarian cancer cells
- (2018) Xiaojing Li et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth
- (2018) Karen McLean et al. ONCOGENE
- Exosomes Released from Tumor-Associated Macrophages Transfer miRNAs That Induce a Treg/Th17 Cell Imbalance in Epithelial Ovarian Cancer
- (2018) Jieru Zhou et al. Cancer Immunology Research
- Do STAT3 inhibitors have potential in the future for cancer therapy?
- (2017) Andrea L.A. Wong et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Targeting STAT3 by HO3867 induces apoptosis in ovarian clear cell carcinoma
- (2017) Kristin Bixel et al. INTERNATIONAL JOURNAL OF CANCER
- Lysyl Oxidase 3 Is a Dual-Specificity Enzyme Involved in STAT3 Deacetylation and Deacetylimination Modulation
- (2017) Li Ma et al. MOLECULAR CELL
- JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
- (2017) Daniella M. Schwartz et al. NATURE REVIEWS DRUG DISCOVERY
- MicroRNA‑519a inhibits the proliferation and promotes the apoptosis of ovarian cancer cells through targeting signal transducer and activator of transcription 3
- (2017) Fei Tian et al. Experimental and Therapeutic Medicine
- Leptin receptor signaling via Janus kinase 2/Signal transducer and activator of transcription 3 impacts on ovarian cancer cell phenotypes
- (2017) Janani Kumar et al. Oncotarget
- IGF-1 induces the epithelial-mesenchymal transition via Stat5 in hepatocellular carcinoma
- (2017) Chuanzong Zhao et al. Oncotarget
- STAT3 is required for MiR-17-5p-mediated sensitization to chemotherapy-induced apoptosis in breast cancer cells
- (2017) Xing-Hua Liao et al. Oncotarget
- IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway
- (2017) Xiongyan Wu et al. Oncotarget
- Tumor-associated macrophages promote neuroblastoma via STAT3 phosphorylation and up-regulation of c-MYC
- (2017) Michael D. Hadjidaniel et al. Oncotarget
- Adipose Stromal Cells from Visceral and Subcutaneous Fat Facilitate Migration of Ovarian Cancer Cells via IL-6/JAK2/STAT3 Pathway
- (2017) Boyun Kim et al. Cancer Research and Treatment
- Differential role of Interleukin-1 and Interleukin-6 in K-Ras-driven pancreatic carcinoma undergoing mesenchymal transition
- (2017) Imran Siddiqui et al. OncoImmunology
- Phosphorylation of STAT3 at Tyr705 regulates MMP-9 production in epithelial ovarian cancer
- (2017) Zan-Hui Jia et al. PLoS One
- The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications
- (2016) Ivo Meinhold-Heerlein et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Cancer-associated fibroblasts attenuate Cisplatin-induced apoptosis in ovarian cancer cells by promoting STAT3 signaling
- (2016) Huan Yan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miRNA-133b and miRNA-135a induce apoptosis via the JAK2/STAT3 signaling pathway in human renal carcinoma cells
- (2016) Wenbin Zhou et al. BIOMEDICINE & PHARMACOTHERAPY
- EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer/T-cell lymphoma
- (2016) Junli Yan et al. BLOOD
- Anticancer potential of diarylidenyl piperidone derivatives, HO-4200 and H-4318, in cisplatin resistant primary ovarian cancer
- (2016) Adam C. ElNaggar et al. CANCER BIOLOGY & THERAPY
- The molecular mechanism of action of superactive human leptin antagonist (SHLA) and quadruple leptin mutein Lan-2 on human ovarian epithelial cell lines
- (2016) Elżbieta Fiedor et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Ovarian cancer stem-like cells differentiate into endothelial cells and participate in tumor angiogenesis through autocrine CCL5 signaling
- (2016) Shu Tang et al. CANCER LETTERS
- Prolactin inhibits a major tumor-suppressive function of wild type BRCA1
- (2016) Kuan-Hui Ethan Chen et al. CANCER LETTERS
- Resistance to Anti-VEGF Therapy Mediated by Autocrine IL6/STAT3 Signaling and Overcome by IL6 Blockade
- (2016) Alexandra Eichten et al. CANCER RESEARCH
- IL-6/STAT3 Plays a Regulatory Role in the Interaction Between Pancreatic Stellate Cells and Cancer Cells
- (2016) Shin Hamada et al. DIGESTIVE DISEASES AND SCIENCES
- High expression of Mcl-1L via the MEK-ERK-phospho-STAT3 (Ser727) pathway protects melanocytes and melanoma from UVB-induced apoptosis
- (2016) Takeshi Fukumoto et al. GENES TO CELLS
- The biological significance and clinical applications of exosomes in ovarian cancer
- (2016) Kalpana Deepa Priya Dorayappan et al. GYNECOLOGIC ONCOLOGY
- Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways
- (2016) BO ZHOU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer
- (2016) Mingzhu Yin et al. JOURNAL OF CLINICAL INVESTIGATION
- Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells
- (2016) Koji Nakamura et al. MOLECULAR CANCER RESEARCH
- Cinnamon extract reduces VEGF expression via suppressing HIF-1α gene expression and inhibits tumor growth in mice
- (2016) Keqiang Zhang et al. MOLECULAR CARCINOGENESIS
- Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target
- (2016) U Saini et al. ONCOGENE
- Exosome-Mediated Metastasis: From Epithelial–Mesenchymal Transition to Escape from Immunosurveillance
- (2016) Nicholas Syn et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer
- (2016) Suqing Liu et al. TUMOR BIOLOGY
- Autocrine interleukin-23 promotes self-renewal of CD133+ ovarian cancer stem-like cells
- (2016) Dan Wang et al. Oncotarget
- Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro
- (2016) Soochi Kim et al. Oncotarget
- Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer
- (2016) Pradeep Chaluvally-Raghavan et al. Cell Reports
- Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer
- (2015) Pooja G. Talati et al. AMERICAN JOURNAL OF PATHOLOGY
- A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer
- (2015) E. M. Dijkgraaf et al. ANNALS OF ONCOLOGY
- Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium
- (2015) C M Nagle et al. BRITISH JOURNAL OF CANCER
- Erythropoietin Stimulates Tumor Growth via EphB4
- (2015) Sunila Pradeep et al. CANCER CELL
- The MutantKRASGene Up-regulates BCL-XL Protein via STAT3 to Confer Apoptosis Resistance That Is Reversed by BIM Protein Induction and BCL-XL Antagonism
- (2015) Aziz Zaanan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary
- (2015) Nozomu Yanaihara et al. MOLECULAR CARCINOGENESIS
- STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells
- (2015) CHUANHAI ZHANG et al. ONCOLOGY REPORTS
- STAT3 Decoy Oligodeoxynucleotides-Loaded Solid Lipid Nanoparticles Induce Cell Death and Inhibit Invasion in Ovarian Cancer Cells
- (2015) Yanhui Ma et al. PLoS One
- Reinforcement of STAT3 activity reprogrammes human embryonic stem cells to naive-like pluripotency
- (2015) Hongwei Chen et al. Nature Communications
- IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3′-diindolylmethane in ovarian cancer cells
- (2015) Minghua Zou et al. CELLULAR ONCOLOGY
- STAT5b as Molecular Target in Pancreatic Cancer—Inhibition of Tumor Growth, Angiogenesis, and Metastases
- (2015) Christian Moser et al. NEOPLASIA
- The IL-6/JAK/Stat3 Feed-Forward Loop Drives Tumorigenesis and Metastasis
- (2015) Qing Chang et al. NEOPLASIA
- Role of the interleukin 6 receptor family in epithelial ovarian cancer and its clinical implications
- (2014) Janani Kumar et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden
- (2014) Khalid Abubaker et al. BMC CANCER
- N-myc downstream-regulated gene 2 (NDRG2) suppresses the epithelial–mesenchymal transition (EMT) in breast cancer cells via STAT3/Snail signaling
- (2014) Myung-Jin Kim et al. CANCER LETTERS
- STAT5 Reactivation by Catechin Modulates H2O2-Induced Apoptosis Through miR-182/FOXO1 Pathway in SK-N-MC Cells
- (2014) Ali Gheysarzadeh et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B and glioblastoma
- (2014) Y Zhang et al. CELL DEATH AND DIFFERENTIATION
- Targeting JAK1/STAT3 Signaling Suppresses Tumor Progression and Metastasis in a Peritoneal Model of Human Ovarian Cancer
- (2014) W. Wen et al. MOLECULAR CANCER THERAPEUTICS
- Synergistic effects of eukaryotic co-expression plasmid-based STAT3-specific siRNA and LKB1 on ovarian cancer in vitro and in vivo
- (2014) YUAN PAN et al. ONCOLOGY REPORTS
- A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients
- (2014) Meiying Zhang et al. Journal of Ovarian Research
- Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
- (2014) Theerawut Chanmee et al. Cancers
- Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden
- (2014) Khalid Abubaker et al. Frontiers in Oncology
- Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3
- (2013) Purnachandra Nagaraju Ganji et al. ANGIOGENESIS
- Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia
- (2013) H. L. M. Rajala et al. BLOOD
- Granulocyte colony-stimulating factor receptor signalling via Janus kinase 2/signal transducer and activator of transcription 3 in ovarian cancer
- (2013) J Kumar et al. BRITISH JOURNAL OF CANCER
- Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour–stroma interaction
- (2013) T Nagasaki et al. BRITISH JOURNAL OF CANCER
- MLS-2384, a new 6-bromoindirubin derivative with dual JAK/Src kinase inhibitory activity, suppresses growth of diverse cancer cells
- (2013) Lucy Liu et al. CANCER BIOLOGY & THERAPY
- Blockage of STAT3 Signaling Pathway with a Decoy Oligodeoxynucleotide Inhibits Growth of Human Ovarian Cancer Cells
- (2013) Ming Liu et al. CANCER INVESTIGATION
- Abrogation of constitutive Stat3 activity circumvents cisplatin resistant ovarian cancer
- (2013) Teng Ji et al. CANCER LETTERS
- Epithelial to Mesenchymal Transition Promotes Breast Cancer Progression via a Fibronectin-dependent STAT3 Signaling Pathway
- (2013) Nikolas Balanis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The tumor microenvironment at a glance
- (2013) F. R. Balkwill et al. JOURNAL OF CELL SCIENCE
- STAT3 mutations are frequent in CD30+ T-cell lymphomas and T-cell large granular lymphocytic leukemia
- (2013) R S Ohgami et al. LEUKEMIA
- Stat3-coordinated Lin-28–let-7–HMGA2 and miR-200–ZEB1 circuits initiate and maintain oncostatin M-driven epithelial–mesenchymal transition
- (2013) L Guo et al. ONCOGENE
- Mutant B-RAF-Mcl-1 survival signaling depends on the STAT3 transcription factor
- (2013) T M Becker et al. ONCOGENE
- AZD1480: A Phase I Study of a Novel JAK2 Inhibitor in Solid Tumors
- (2013) E. R. Plimack et al. ONCOLOGIST
- The Ratios of CD8+ T Cells to CD4+CD25+ FOXP3+ and FOXP3- T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer
- (2013) Claudia C. Preston et al. PLoS One
- Expression of M2-Polarized Macrophages is Associated with Poor Prognosis for Advanced Epithelial Ovarian Cancer
- (2013) Chunyan Lan et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer
- (2012) M Aapro et al. BRITISH JOURNAL OF CANCER
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- The upregulation of signal transducer and activator of transcription 5-dependent microRNA-182 and microRNA-96 promotes ovarian cancer cell proliferation by targeting forkhead box O3 upon leptin stimulation
- (2012) Xiaofei Xu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Leukotriene B4Receptor-2 Promotes Invasiveness and Metastasis of Ovarian Cancer Cells through Signal Transducer and Activator of Transcription 3 (STAT3)-dependent Up-regulation of Matrix Metalloproteinase 2
- (2012) Ji-Min Seo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Efficient inhibition of intraperitoneal ovarian cancer growth in nude mice by liposomal delivery of short hairpin RNA against STAT3
- (2012) Qingyuan Jiang et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- p53 mutations in cancer
- (2012) Patricia A. J. Muller et al. NATURE CELL BIOLOGY
- SomaticSTAT3Mutations in Large Granular Lymphocytic Leukemia
- (2012) Hanna L.M. Koskela et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ten-Year Relative Survival for Epithelial Ovarian Cancer
- (2012) Lauren A. Baldwin et al. OBSTETRICS AND GYNECOLOGY
- Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors
- (2012) Ardian Latifi et al. PLoS One
- HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition
- (2011) Karuppaiyah Selvendiran et al. CANCER BIOLOGY & THERAPY
- Stat3 and MMP7 Contribute to Pancreatic Ductal Adenocarcinoma Initiation and Progression
- (2011) Akihisa Fukuda et al. CANCER CELL
- Ovarian cancer: Stat3, RhoA and IGF-IR as therapeutic targets
- (2011) Caroline Gest et al. CANCER LETTERS
- IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer
- (2011) M. S. Anglesio et al. CLINICAL CANCER RESEARCH
- Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
- (2011) Jermaine Coward et al. CLINICAL CANCER RESEARCH
- Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2
- (2011) Malay Mandal et al. NATURE IMMUNOLOGY
- Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
- (2011) Kristin M Nieman et al. NATURE MEDICINE
- Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells
- (2011) P Yue et al. ONCOGENE
- Knockdown of stat3 expression by RNAi inhibits in vitro growth of human ovarian cancer
- (2011) Shu-Hua Zhao et al. Radiology and Oncology
- Oxygenation inhibits ovarian tumor growth by down-regulating STAT3 and cyclin-D1 expressions
- (2010) Karuppaiyah Selvendiran et al. CANCER BIOLOGY & THERAPY
- Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo
- (2010) Sha Hu et al. CANCER BIOLOGY & THERAPY
- Role of STAT3 decoy oligodeoxynucleotides on cell invasion and chemosensitivity in human epithelial ovarian cancer cells
- (2010) Xiaolei Zhang et al. CANCER GENETICS AND CYTOGENETICS
- Involvement of M2-polarized macrophages in the ascites from advanced epithelial ovarian carcinoma in tumor progression via Stat3 activation
- (2010) Kiyomi Takaishi et al. CANCER SCIENCE
- Estrogen receptor alpha pathway is involved in leptin-induced ovarian cancer cell growth
- (2010) Jung-Hye Choi et al. CARCINOGENESIS
- Effects of Siltuximab on the IL-6-Induced Signaling Pathway in Ovarian Cancer
- (2010) Y. Guo et al. CLINICAL CANCER RESEARCH
- Curcumin suppresses constitutive activation of STAT-3 by up-regulating protein inhibitor of activated STAT-3 (PIAS-3) in ovarian and endometrial cancer cells
- (2010) Manush Saydmohammed et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Enhancer of Zeste Homolog 2 Promotes the Proliferation and Invasion of Epithelial Ovarian Cancer Cells
- (2010) H. Li et al. MOLECULAR CANCER RESEARCH
- Anticancer Efficacy of a Difluorodiarylidenyl Piperidone (HO-3867) in Human Ovarian Cancer Cells and Tumor Xenografts
- (2010) K. Selvendiran et al. MOLECULAR CANCER THERAPEUTICS
- Oncoproteomic Analysis Reveals Co-Upregulation of RELA and STAT5 in Carboplatin Resistant Ovarian Carcinoma
- (2010) Natini Jinawath et al. PLoS One
- Enhancement of TRAIL cytotoxicity by AG-490 in human ALL cells is characterized by downregulation of cIAP-1 and cIAP-2 through inhibition of Jak2/Stat3
- (2009) Paola Lanuti et al. CELL RESEARCH
- Mutations in the KRAS gene in ovarian tumors.
- (2009) Bozena Dobrzycka et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- Multicellular spheroids in ovarian cancer metastases: Biology and pathology
- (2009) Kristy Shield et al. GYNECOLOGIC ONCOLOGY
- Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3
- (2009) Karuppaiyah Selvendiran et al. INTERNATIONAL JOURNAL OF CANCER
- Histologic Subtypes of Ovarian Carcinoma
- (2009) Robert A. Soslow INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup
- (2009) Michael A. Bookman et al. JOURNAL OF CLINICAL ONCOLOGY
- Constitutive activation of signal transducer and activator of transcription 3 in epithelial ovarian carcinoma
- (2009) Hao Min et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer
- (2009) Shahab Uddin et al. Molecular Cancer
- Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial–mesenchymal transition in ovarian carcinomas
- (2008) M Colomiere et al. BRITISH JOURNAL OF CANCER
- Co-overexpression of Janus kinase 2 and signal transducer and activator of transcription 5a promotes differentiation of mammary cancer cells through reversal of epithelial–mesenchymal transition
- (2008) Ahmed S. Sultan et al. CANCER SCIENCE
- Hyaluronan-CD44 Interaction Activates Stem Cell Marker Nanog, Stat-3-mediated MDR1 Gene Expression, and Ankyrin-regulated Multidrug Efflux in Breast and Ovarian Tumor Cells
- (2008) Lilly Y. W. Bourguignon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer
- (2008) Y. Miyahara et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comparison of STAT3 with HIF-1alpha, Ob and ObR expressions in human endometrioid adenocarcinomas
- (2008) Andrzej Wincewicz et al. TISSUE & CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started